Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 426.70
Bid: 427.30
Ask: 427.50
Change: 0.00 (0.00%)
Spread: 0.20 (0.047%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 426.70
RR. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Dec 2020 07:00

RNS Number : 3043I
Rolls-Royce Holdings plc
11 December 2020
 

11 December 2020

 

ROLLS-ROYCE HOLDINGS PLC TRADING UPDATE

 

· Restructuring plans on track to deliver our targeted £1.3bn cost savings by 2022; at least £1bn of near-term cash cost mitigations confirmed for 2020

· Power Systems end markets seeing some early signs of improvement

· Defence remains resilient with strong order cover for 2021

· Civil Aerospace large engine flying hours gradually recovering; year-to-date 42% of 2019

· £5bn package completed in November to increase resilience, strengthen the balance sheet and support long-term strategy

· Expected 2020 FCF of approximately £(4.2)bn, subject to timing of year-end working capital cash flows; resulting in year-end net debt £1.5bn - £2.0bn and liquidity £8.5bn - £9.0bn

· Guidance unchanged: we expect to turn cash flow positive at some point during H2 2021, target at least £750m free cash flow (excluding disposals) as early as 2022 and at least £2 billion from disposal proceeds

 

Warren East, CEO, said: "We have taken decisive actions to protect and reposition our business in difficult and uncertain trading conditions, including the impact from a second wave of COVID-19. We have made rapid progress on our restructuring programme and the consolidation and reorganisation of our Civil Aerospace footprint is well underway. Our £5 billion recapitalisation package in November was well supported and has increased our resilience and strengthened our balance sheet. The outlook remains challenging and the pace and timing of the recovery is uncertain. However, our actions have given us a strong foundation to deliver better returns as our end markets improve and we continue to drive our ambition of delivering more sustainable power to support the creation of a net zero carbon economy."

 

Trading update for 11 months to end November

Prior to COVID-19 we were reaching a pivotal point in Civil Aerospace. Following a period of rapid growth and new engine programme launches, R&D investment demands were falling and returns improving as we began to benefit from our large and growing installed base and reduced losses on new installed engines. The benefits from this have been delayed due to COVID-19, but the fundamental drivers of having a more efficient business with stronger margins and better returns remain intact and position us well for the eventual rebound.

 

In the 11-month period to end November, large engine LTSA invoiced flying hours (EFH) were approximately 42% of their prior year level. EFH have gradually improved since the trough in April although more recently the pace of recovery has slowed due to the second wave of infections in some geographies. In October and November combined, EFH increased to approximately 33% compared to 2019. In Q3 our EFH were 29% of the prior year, an improvement versus the 24% seen in Q2. We have reduced the pace of production for our large engines and our full-year guidance for approximately 250 deliveries is unchanged.

 

Business aviation has continued to see less of an impact than scheduled commercial flights with flying hours holding up relatively well, despite border restrictions being in place in many parts of the world.

 

Our Defence business has remained resilient with good cash conversion. We have a strong order book and 2021 forecast sales are well covered. In recent months we have secured orders for 56 new EJ200 engines for the German Air Force and reached an agreement to provide in-service support for the T-55 engine, should it be selected as the future heavy transport helicopter of the German Bundeswehr. We continue to focus on key growth opportunities for our core products in the US and the UK. The recently announced multi-year Defence budget increase in the UK will provide additional investment for next generation capabilities, such as the Future Combat Air System where we are a core partner in the growing Tempest programme. In addition, we are innovating in adjacent products and growing our aftermarket revenues from our large installed base.

 

Power Systems has experienced a significant fall in demand in most non-governmental end markets this year. The activity declines seen in the second quarter caused by the pandemic continued into the second half of the year, except in China where economic activity has recovered more quickly and we have continued to grow our market share. In recent months, we have seen some early indications of order intake levels picking up and year-to-date our net book:bill ratio has been approximately 1x. In November, at the China International Import Expo, we announced provisional agreements with six Chinese companies for almost 1,000 MTU engines and systems.

 

Our Small Modular Reactor (SMR) consortium has signed strategic agreements with Exelon Generation and CEZ and the UK Government has committed £215m for a four-year development plan for SMRs. This highlights the appeal and opportunities of our nuclear energy solution to support the decarbonisation of power generation in the UK and abroad.

 

In line with the challenging Civil Aerospace market trends, ITP Aero has seen a continued negative impact on trading. Defence, which represents 25% of ITP Aero volumes, benefited from the Eurofighter order from the German Airforce for 56 EJ200 engines.

 

Taking actions to protect our business

The pandemic is causing a reduction in demand for our Civil Aerospace products and services that we expect will take several years to recover and as a result we announced, on 20 May, a major reorganisation programme. We have made good progress towards our target for £1.3 billion of pre-tax cash cost savings and a reduction of at least 9,000 roles by the end of 2022. More than 5,500 roles will have been removed by the year end, ahead of our prior expectation of over 5,000, with a significant proportion achieved through voluntary severance. We are in consultation regarding the next phase of our Civil Aerospace footprint review, which includes a proposal to transfer our facility and workforce in Hucknall, UK, which manufactures a range of aero-engine parts, into ITP Aero. We are also proposing to consolidate the manufacture of aero-engine structures into ITP Aero. These difficult but necessary decisions will help generate efficiency savings for the Group and strengthen ITP Aero's capabilities.

 

Our mitigating actions to preserve cash in 2020 are on track to deliver more than £1 billion of in-year savings in 2020. We expect approximately £4.2 billion free cash outflow in 2020, reflecting the impact of the second wave on flying hours in the fourth quarter. The actual outturn will be influenced by the timing of significant working capital cash flows around the year-end, in particular for original equipment concession payments which depend on the timing of new aircraft deliveries to airlines.

 

Rebuilding our balance sheet and increasing our financial resilience are key to our ability to position our company for the future. Our £5 billion recapitalisation package, completed in November, comprised £2 billion of new equity, £2 billion in new bonds with maturity in 2026/2027 and a £1 billion 2-year bank facility that remains undrawn. This extended and replaced shorter term facilities including an undrawn £1.9 billion revolving credit facility which was cancelled when the new financing was finalised. As a result, we expect to end the year with net debt of between £1.5 billion and £2.0 billion, excluding lease liabilities of approximately £2.1 billion, and liquidity between £8.5 billion and £9.0 billion.

 

Disposal update

In December we signed an agreement to sell our civil nuclear instrumentation and control business, the first of a number of disposals that we have under consideration. This transaction is expected to conclude in the second half of 2021 and contributes towards our target of generating at least £2 billion from disposals, as announced in August. Other assets under consideration for disposal include ITP Aero and our medium speed gas and diesel engines business, Bergen Engines.

 

Looking forwards

As we look ahead, we are confident in our plans to position the business for the recovery as we deliver our reorganisation programme in Civil Aerospace to align to future demand and realise the opportunities for future growth as our end markets recover. The fundamental drivers behind long-term growth in global commercial flights remain intact.

 

While many of our end markets continue to be significantly affected by COVID-19, we will continue to actively respond to any changing timing of recovery and the recent news on effective vaccines is encouraging. Commercial air travel looks likely to recover slowly in the first half of 2021, reflecting the reduced winter schedules planned by the airlines and continuing the trends seen in the second half of 2020. We anticipate an improvement in the second half of 2021 as vaccination programmes support the further reopening of borders and economic recovery.

 

We continue to expect the Group to turn cash flow positive at some point during the second half of 2021, as we mitigate the uncertainty of the timing and shape of the recovery through cost-saving and capital allocation actions. Our target to deliver at least £750 million free cash flow (excluding disposals) as early as 2022 is also unchanged.

 

Trading update conference call at 09:00 (GMT) today

UK dial-in: 0333 300 0804 / US dial-in: +1 631 913 1422 / International dial-in: +44 333 300 0804

Participant passcode: 7893 9687#

 

A replay will be available shortly after the call has concluded

UK dial-in: 0333 300 0819 / US dial-in: +1 866 931 1566 / International dial-in: +44 333 300 0819

Participant passcode: 3013 34996#

 

Our 2020 Full Year results announcement will be published on 11 March 2021.

 

 

For further information, please contact:

Media

Richard Wray

Director of External Communications & Brand, Rolls-Royce plc

Tel +44 (0) 7810 850055

Richard.Wray@Rolls-Royce.com

 

Investors

Isabel Green

Head of Investor Relations, Rolls-Royce plc

Tel +44 (0) 7880 160976

Isabel.Green@Rolls-Royce.com

www.Rolls-Royce.com

 

 

About Rolls-Royce Holdings plc

 

1. Rolls-Royce pioneers cutting-edge technologies that deliver clean, safe and competitive solutions to meet our planet's vital power needs.

 

2. Rolls-Royce has customers in more than 150 countries, comprising more than 400 airlines and leasing customers, 160 armed forces, 70 navies, and more than 5,000 power and nuclear customers.

 

3. Annual underlying revenue was £15.3 billion in 2019, around half of which came from the provision of aftermarket services.

 

4. In 2019, Rolls-Royce invested £1.45 billion on research and development. We also support a global network of 29 University Technology Centres, which position Rolls-Royce engineers at the forefront of scientific research.

 

5. Rolls-Royce Holdings plc LEI: 213800EC7997ZBLZJH69

 

Note on forward-looking statements

This press release may contain projections and forward-looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward-looking statements. All statements other than statements of historical facts included in this press release, including, without limitation, those regarding the Company's financial position, potential business strategy, potential plans and potential objectives, are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. Further, certain forward-looking statements are based upon assumptions of future events which may not prove to be accurate. The forward-looking statements in this press release speak only as at the date of this press release and the Company assumes no obligation to update or provide any additional information in relation to such forward-looking statements.

 

The merits or suitability of investing in any securities previously issued or issued in future by the Company for any investor's particular situation should be independently determined by such investor. Any such determination should involve, inter alia, an assessment of the legal, tax, accounting, regulatory, financial, credit and other related aspects of the transaction in question.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFSIFLLILII
Date   Source Headline
26th Mar 202411:00 amRNSDirector/PDMR Shareholding
13th Mar 20249:00 amRNSDirector/PDMR Shareholding
8th Mar 20241:45 pmRNSDirector/PDMR Shareholding
6th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 202411:30 amRNSDirector/PDMR Shareholding
29th Feb 20249:00 amRNSAGM Statement
28th Feb 20243:30 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:30 amRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSFull Year Results 2023
8th Feb 20244:00 pmRNSDirector/PDMR Shareholding
26th Jan 20243:00 pmRNSDirector/PDMR Shareholding
10th Jan 202411:45 amRNSDirector/PDMR Shareholding
21st Dec 20232:00 pmRNSDirector/PDMR Shareholding
21st Dec 20231:58 pmRNSDirector/PDMR Shareholding
20th Dec 202310:00 amRNSHolding(s) in Company
11th Dec 20233:45 pmRNSHolding(s) in Company
8th Dec 202312:00 pmRNSDirector/PDMR Shareholding
1st Dec 20234:00 pmRNSTotal Voting Rights
1st Dec 20233:50 pmRNSDirector/PDMR Shareholding
1st Dec 20233:45 pmRNSDirector/PDMR Shareholding
29th Nov 20232:15 pmRNSDirector/PDMR Shareholding
29th Nov 20231:00 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSCapital Markets Day
8th Nov 202311:30 amRNSDirector/PDMR Shareholding
30th Oct 202310:15 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSRolls-Royce creates more efficient organisation
11th Oct 20232:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20239:30 amRNSHolding(s) in Company
28th Sep 202310:30 amRNSDirector/PDMR Shareholding
11th Sep 20239:30 amRNSDirector/PDMR Shareholding
25th Aug 20232:45 pmRNSDirector/PDMR Shareholding
8th Aug 202312:30 pmRNSDirector/PDMR Shareholding
8th Aug 20239:45 amRNSDirector/PDMR Shareholding
4th Aug 202311:51 amRNSHolding(s) in Company
3rd Aug 20237:00 amRNS2023 Half Year Results
2nd Aug 20237:00 amRNSDirectorate Change
31st Jul 20239:30 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
20th Jul 20239:00 amRNSDirectorate Change
10th Jul 20233:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:32 amRNSTotal Voting Rights
28th Jun 20233:30 pmRNSDirector/PDMR Shareholding
27th Jun 202312:00 pmRNSAdmission of Shares
8th Jun 20232:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
19th May 202312:00 pmRNSDirector/PDMR Shareholding
11th May 20232:07 pmRNSResult of AGM
11th May 20239:14 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAGM Statement and Trading Update
10th May 20234:00 pmRNSDirectorate change & withdrawal of AGM resolution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.